课题基金 / 基金详情

Novel non-invasive imaging of amyloid in the retina of the eye as a predictor of amyloid in the brain in Alzheimer's disease

Novel non-invasive imaging of amyloid in the retina of the eye as a predictor of amyloid in the brain in Alzheimer's disease
眼睛视网膜中淀粉样蛋白的新型非侵入性成像可作为阿尔茨海默病大脑中淀粉样蛋白的预测因子
批准号：
337242
负责人：
Campbell Melanie Crombie W
金额：
$29.6万
依托单位：
University of Waterloo (Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-10-01 至 2018-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=337242&lang=en
关键词：
Alzheimer'S Disease Amyloid Biomarker Asssessment And Diagnosis Biomedical Engineering Biomedical Technology Medical Equipment And Apparatus Neuroimaging Optical Imaging Of The Retina Photonics Polarization Imaging

项目摘要

项目成果

Campbell Melanie Crombie W的其他基金

相似基金

相关文献

中文摘要
翻译
阿尔茨海默病（AD）目前无法治愈，通常无法在早期阶段诊断出来。这种疾病对患者及其家人、照顾者和整个社会都有很大的影响。目前可能的阿尔茨海默病是通过临床评估诊断的
英文摘要
Alzheimer's disease (AD) currently cannot be cured and is often not diagnosed in its early stages. The disease has a large impact on patients as well as their families, caregivers and society as a whole. Probable AD is currently diagnosed by clinical eval
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Diagnostic Methods for Imaging Amyloid Beta in the eye in association with alzheimer's disease
  • 批准号：
    251106
  • 项目类别：
    Operating Grants
  • 资助金额：
    $17.85万
  • 财政年份：
    2011
  • 负责人：
    Campbell Melanie Crombie W
  • 依托单位：
    University of Waterloo (Ontario)
海外基金